Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma

Neel M. Fofaria(Texas Tech University Health Sciences Center), Sanjay Srivastava(Texas Tech University)
Oncotarget
October 14, 2015
Cited by 62


Related Papers